Viewing Study NCT00319332


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-25 @ 7:34 PM
Study NCT ID: NCT00319332
Status: WITHDRAWN
Last Update Posted: 2015-04-17
First Post: 2006-04-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module